Oncolytic viruses get a boost with first FDA-approval recommendation
Elie Dolgin • June 1, 2015
The future of cancer-killing viruses lies in their potential to augment cell and antibody immunotherapies.
Continue reading here.
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.